⌘K

Login Start Free

Home/Filings/4/0001650664-24-000068

4//SEC Filing

Hirsch Andrew 4

Accession 0001650664-24-000068

CIK 0001650664other

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 5:11 PM ET

Size

5.3 KB

Accession

0001650664-24-000068

Insider Transaction Report

Form 4

Period: 2024-05-30

Editas Medicine, Inc.EDIT

Director

Transactions

Award
Stock Option (right to buy)
2024-05-30+25,000→ 25,000 total
Exercise: $5.17Exp: 2034-05-29→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]This option was granted on May 30, 2024 and is scheduled to vest in full on May 30, 2025.

Documents

1 file

4
wk-form4_1717449062.xmlPrimary
FORM 4

Issuer

Editas Medicine, Inc.

CIK 0001650664

Entity typeother

Related Parties

1

filerCIK 0001586707

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 5:11 PM ET
Size: 5.3 KB

View on SEC.gov